Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

DEL VALLE, Texas — A Central Texas man has been sentenced to 10 years in national prison after he was caught selling fake ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain ...